Moreover, experimental validation supported the involvement of HERC6, IFI44L, and RSAD2 in SLE-related cardiac dysfunction, with HERC6 showing the most pronounced upregulation in doxorubicin-treated H9C2 cardiomyocytes. This evidence concerns the gene HERC6 and systemic lupus erythematosus.